F Hoffman-La Roche Ltd v Cipla Ltd Expert Analysis


The long awaited Hoffman-La Roche v. Cipla judgement was finally passed last week marking the end of the first phase of a key battle between Big Pharma and the Indian generic industry. Although there are pending suits before the Delhi High Court which have been filed by Roche against several other generics, most prominently NATCO, Glenmark and Dr. Reddy’s, it is expected that the finding of non-infringement against Cipla will pre-determine the fate of those lawsuits as well. Shwetasree Majumder dissects the 275 page judgement and analyses the various issues argued and the court’s ruling. By Shwetasree Majumder   Opening […]